RecruitingNCT07416747
GynMDD or placebo added to psychotherapy for mild to moderate depression
About this title
Read the official source — NCT07416747Placebo comparisonAges 18–65France
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
What will I do during this study?
Participants attend one supportive-psychotherapy session each week for eight weeks and take GynMDD or placebo (an inactive comparison treatment) daily. They complete weekly app questionnaires about mood, digestive symptoms and side effects, and provide stool samples at the beginning and end of the study.
- Listed locations
- CréteilSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 24, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 168
- Sponsor
- Fondation FondaMental
- Sponsor type
- Non-profit organization
- Study type
- Other
- Intervention type
- DIETARY_SUPPLEMENT, OTHER
- Study phase
- Not clearly listed
- Locations
- France
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT07416747
- Official title
Show the full official title
Multicenter Interventional Real-world Study Evaluating the Impact of the Dietary Supplement GynMDD Administered as an add-on to Supportive Psychotherapy in Patients With Mild to Moderate Depression.
Recruitment & locations
RecruitingCréteil
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Fondation FondaMental.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
